COVID-19 and the Pancreas: A Narrative Review
- PMID: 36143329
- PMCID: PMC9504204
- DOI: 10.3390/life12091292
COVID-19 and the Pancreas: A Narrative Review
Abstract
The outbreak of COVID-19, initially developed in China in early December 2019, has rapidly spread to other countries and represents a public health emergency of international concern. COVID-19 has caused great concern about respiratory symptoms, but it is worth noting that it can also affect the gastrointestinal tract. However, the data on pancreatic involvement during SARS-CoV-2 infection are limited. The prevalence and severity of pancreatic damage and acute pancreatitis, as well as its pathophysiology, are still under debate. Moreover, the possible implication of pancreatic damage as an apparent adverse effect of COVID-19 therapies or vaccines are issues that need to be addressed. Finally, the COVID-19 pandemic has generated delays and organizational consequences for pancreatic surgery, an element that represent indirect damage from COVID-19. This narrative review aims to summarize and analyze all the aspects of pancreatic involvement in COVID-19 patients, trying to establish the possible underlying mechanisms and scientific evidence supporting the association between COVID-19 and pancreatic disease.
Keywords: COVID-19; SARS-CoV-2; coronavirus; pancreas; pancreatitis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- WHO Coronavirus Disease (COVID-19) Dashboard. 2022. [(accessed on 19 July 2022)]. Available online: https://covid19.who.int/?adgroupsurvey=%7Badgroupsurvey%7D&gclid=EAIaIQo....
-
- Zippi M., Hong W., Traversa G., Maccioni F., De Biase D., Gallo C., Fiorino S. Involvement of the exocrine pancreas during COVID-19 infection and possible pathogenetic hypothesis: A concise review. Infez. Med. 2020;28:507–515. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
